COVID-19 Resources and Projects

In 2020, researchers across UC Berkeley redirected their investigations to address the challenges of the COVID-19 crisis. Learn about all the ways our experts offered solutions across disciplines.

University technology transfer made significant contributions to fighting COVID-19 while ensuring global access (Healthcare Policy 17(4) May 2022). For example, UC Berkeley, which started incorporating global health provisions in its license agreements as early as 2003 to facilitate affordable access to its innovations in low- and middle-income countries, discovered a new implementation of CRISPR. The inclusion of global health protection terms when licensing the technology to Mammoth Biosciences led to the development of a high throughput COVID-19 test, whiich was granted emergency use authorization by the FDA in January 2022.

Photo courtesy of Max & Jules Photography.

Below, you'll find special licensing resources to incentivize rapid utilization of UC Berkeley technologies related to COVID-19, as well as examples of how UC Berkeley partnered with industry to mitigate this pandemic.

Please contact IPIRA for information related to:

• • Intellectual Property Licensing
• • Receiving and Sending Materials and Data
• • Corporate Sponsored Research
• • Entrepreneurship

For campus policies and resources related to COVID-19, incuding health and safety information, see UC Berkeley's response to the coronavirus outbreak.